DEA tells court that Right to Try law doesn’t supersede CSA in psilocybin case

DEA tells court that Right to Try law doesn’t supersede CSA in psilocybin case 
PsychedelicNewsWire; 4/30/24
The U.S. Drug Enforcement Administration (DEA) is claiming that a federal law that affords severely ill individuals the right to try investigational medications doesn’t apply to drugs classified under the Controlled Substances Act. This is in response to a lawsuit filed by a doctor in Washington state who sought permission to legally administer psilocybin as treatment for patients in end-of-life care with cancer. The agency argues that because drugs classified under Schedule I are said to have no accepted medical use, the law prevents them from being dispensed, even by professionals.